203 related articles for article (PubMed ID: 33264784)
1. Fibroblast Growth Factor 21 Correlates with the Prognosis of Dilated Cardiomyopathy.
Gu L; Jiang W; Zheng R; Yao Y; Ma G
Cardiology; 2021; 146(1):27-33. PubMed ID: 33264784
[TBL] [Abstract][Full Text] [Related]
2. High serum fibroblast growth factor 21 levels were related to the prognosis and ventricular remodeling of heart failure patients with mildly reduced and reduced ejection fraction.
Fan L; Gu L; Yao Y; Ma G
Perfusion; 2024 Mar; 39(2):285-293. PubMed ID: 36321746
[TBL] [Abstract][Full Text] [Related]
3. Correlation of plasma TSG-6 with cardiac function, myocardial fibrosis, and prognosis in dilated cardiomyopathy patients with heart failure.
Xu L; Zhang Y; Kuang Y; Fang H; Ma Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):689-696. PubMed ID: 34382584
[TBL] [Abstract][Full Text] [Related]
4. Outcome and prognostic value of N-terminal pro-brain natriuretic peptide and high-sensitivity C-reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy.
Feng J; Tian P; Liang L; Chen Y; Wang Y; Zhai M; Huang Y; Zhou Q; Zhao X; Zhao L; Huang B; Huang L; Zhang Y; Zhang J
ESC Heart Fail; 2022 Jun; 9(3):1625-1635. PubMed ID: 35243815
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
[No Abstract] [Full Text] [Related]
6. [Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients].
Zhao XY; Yang YJ; Zhang J; Kang LM; Wei BQ; Gao XJ; Lü R; Zhang CL
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):486-90. PubMed ID: 19927626
[TBL] [Abstract][Full Text] [Related]
7. Study of the Role of Plasma NT-proBNP in the Diagnosis of Heart Failure.
Athavale B; Pathak J
J Assoc Physicians India; 2022 Jul; 70(7):11-12. PubMed ID: 35833396
[TBL] [Abstract][Full Text] [Related]
8. Effect of trimetazidine combined with perindopril on NT-proBNP level in rats with dilated cardiomyopathy.
Lin J; Zhong B; Yan J; Chen L
Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):198-203. PubMed ID: 32415948
[TBL] [Abstract][Full Text] [Related]
9. Circulating Omentin-1 Levels Are Decreased in Dilated Cardiomyopathy Patients with Overt Heart Failure.
Huang Y; Lin Y; Zhang S; Wang Z; Zhang J; Chang C; Liu L; Ji Q; Liu X
Dis Markers; 2016; 2016():6762825. PubMed ID: 27313334
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm.
Tigen K; Karaahmet T; Kahveci G; Tanalp AC; Bitigen A; Fotbolcu H; Bayrak F; Mutlu B; Basaran Y
Heart Lung Circ; 2007 Aug; 16(4):290-4. PubMed ID: 17403613
[TBL] [Abstract][Full Text] [Related]
11. Heart failure biomarkers in patients with dilated cardiomyopathy.
Bielecka-Dabrowa A; von Haehling S; Aronow WS; Ahmed MI; Rysz J; Banach M
Int J Cardiol; 2013 Oct; 168(3):2404-10. PubMed ID: 23416015
[TBL] [Abstract][Full Text] [Related]
12. Elevated Serum Fibroblast Growth Factor 21 Is Relevant to Heart Failure Patients with Reduced Ejection Fraction.
Fan L; Gu L; Yao Y; Ma G
Comput Math Methods Med; 2022; 2022():7138776. PubMed ID: 35069790
[TBL] [Abstract][Full Text] [Related]
13. Old markers, new approach to assessment of risk in heart failure.
Kodziszewska K; Leszek P; Korewicki J; Piotrowski W
Kardiol Pol; 2015; 73(6):387-95. PubMed ID: 25563469
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of S100A4, S100A8/A9, and S100A12 in dilated cardiomyopathy: novel biomarkers for diagnosis or prognosis?
Yu Y; Shi H; Wang Y; Yu Y; Chen R
ESC Heart Fail; 2024 Feb; 11(1):503-512. PubMed ID: 38083998
[TBL] [Abstract][Full Text] [Related]
15. [Changes in serum chromogranin A and urotensin II levels in children with chronic heart failure].
Cheng YY; An JD; Feng S; Ge W
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Mar; 19(3):313-317. PubMed ID: 28302203
[TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.
Tigen K; Karaahmet T; Cevik C; Gurel E; Mutlu B; Basaran Y
Am J Med Sci; 2009 Feb; 337(2):109-15. PubMed ID: 19214026
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of NT-proBNP in Patients With Successful PCI for ACS and Normal Left Ventricular Ejection Fraction.
Wang JL; Guo CY; Li HW; Zhao XQ; Zhao SM
Am J Med Sci; 2022 Apr; 363(4):333-341. PubMed ID: 34986361
[TBL] [Abstract][Full Text] [Related]
18. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
19. [Predictive value of N-terminal B-type natriuretic peptide on outcome of elderly hospitalized non-heart failure patients].
Li YY; Liang YD; Yao SM; Zheng PP; Zeng XZ; Cui LL; Guo D; Wang H; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):661-668. PubMed ID: 32847322
[No Abstract] [Full Text] [Related]
20. Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure.
Rusconi PG; Ludwig DA; Ratnasamy C; Mas R; Harmon WG; Colan SD; Lipshultz SE
Am Heart J; 2010 Oct; 160(4):776-83. PubMed ID: 20934575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
